BioLife Solutions - BLFS Net earnings per share growth forecast for next year
Due to the absence of geopolitical risks and sanction restrictions, BioLife Solutions, Inc. (BLFS) is steadily scaling global sales. The projected net profit growth rate for n+1 visualizes market expectations, where the value of -43.80 reflects the metric's balance. The business relies on the supply of cryopreservation tools for cancer therapy, generating excess profits from the sale of proprietary consumables for its smart freezers.
Analytical breakdowns and data insights for company biolifesolutions.com (BLFS)
- stock quotes and analyst forecast:
- issuer market value details:
- company book value details:
- debt and liquidity data:
Total Debt to Equity Ratio BioLife Solutions, Inc.|BLFS - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio BioLife Solutions|BLFS - Company Cumulative Indebtedness|Debts to Book Capitalization BioLife Solutions|BLFS - Long-Term Debt Volume|Company Short-Term Debt BioLife Solutions|Quick Liquidity biolifesolutions.com
- net income and valuation ratios data:
BLFS - Company Profit|Expected Profit BioLife Solutions, Inc.|BLFS - Business Payback Period|Projected Price to Earnings BioLife Solutions, Inc.|BLFS - Growth-Adjusted Payback Ratio|EV/EBITDA Multiple BioLife Solutions|BLFS - Operating income before deduction of amortization|Earnings per share for the last twelve months BioLife Solutions|BLFS - Earnings per share for the last 12 months|Quarterly EPS earnings growth biolifesolutions.com|BLFS - Net earnings per share growth this year|Expected earnings per share growth for next year BioLife Solutions, Inc.
Fundamental valuation:BioLife Corp, BLFS
This indicator aggregates current analyst consensus forecasts for net income changes, reflecting the expected return dynamics of the asset for the coming year. Analyzing the projected earnings per share for next year allows for an assessment of how the R&D pipeline of cryopreservatives and ThawSTAR systems will impact future capitalization, where increased volatility in the curve signals uncertainty regarding the monetization of new technological solutions from BioLife Solutions, Inc. (BLFS).
Competitor analysis
Expected earnings per share growth for next year TEM|QGEN: Expected earnings per share trend next year|Net earnings per share growth forecast for next year Ionis Pharmaceuticals (IONS)|Consensus forecast of earnings per share growth for next year repligen.com|Net earnings per share growth forecast for next year Avidity Biosciences, Inc. RNA|CRISPR Therapeutics Inc (CRSP) - Expected net earnings per share growth next year|WGS - Net earnings per share growth forecast for next year|RARE: Net earnings per share growth forecast for next year|BEAM (Beam Therapeutics Inc.) - Expected earnings per share growth for next year|sarepta.com (SRPT) - Earnings growth forecast for next year|Expected earnings per share growth for next year TWST|TXG (10x Genomics Inc) - Projected earnings per share increase next year|Earnings growth forecast for next year NTLA|Consensus forecast of earnings per share growth for next year Stoke Corp|Net earnings per share growth forecast for next year Wave Life Sciences WVE|mazetx.com (MAZE) - Expected net earnings per share growth next year|SION - Net earnings per share growth forecast for next year|PRME (Prime Medicine Inc) - Projected earnings per share growth rate for next year|Taysha (TSHA) - Net earnings per share growth forecast for next year|QURE - Consensus forecast of earnings per share growth for next year|Expected earnings per share growth for next year MGTX|RGNX: Expected earnings per share trend next year|Earnings growth forecast for next year SLDB|Consensus forecast of earnings per share growth for next year Ocugen Inc|Net earnings per share growth forecast for next year Pacific Biosciences of California PACB|BNTC: Projected earnings per share growth rate for next year|Design Therapeutics - Earnings growth forecast for next year|rocketpharma.com (RCKT) - Expected earnings per share growth for next year|FDMT (4D Molecular Therapeutics, Inc.) - Expected earnings per share growth for next year|LXEO - Consensus forecast of earnings per share growth for next year|KRRO (Korro Bio Inc.) - Earnings growth forecast for next year|Net earnings per share growth forecast for next year EDIT|Net earnings per share growth forecast for next year Silence Therapeutics (SLN)|Net earnings per share growth forecast for next year PRQR (proqr.com)|Earnings growth forecast for next year CDXS (Codexis)|SGMO (Sangamo Therapeutics Inc.) - Net earnings per share change forecast for next year|NAUT - Net earnings per share growth forecast for next year|Consensus forecast of earnings per share growth for next year Metagenomi Therapeutics MGX|DTIL: Earnings growth forecast for next year|Projected earnings per share growth rate for next year GBIO|Net earnings per share growth forecast for next year Boundless Bio|Projected earnings per share growth rate for next year XCUR (Exicure Corp)|Earnings growth forecast for next year IMNN|Earnings growth forecast for next year phiopharma.com (PHIO)|Earnings growth forecast for next year MBIO (Mustang Bio)|TransCode Therapeutics Inc. - Net earnings per share growth forecast for next year|Bionano - Earnings growth forecast for next year|Consensus forecast of earnings per share growth for next year Applied DNA Sciences Inc APDN|Bluebird Bio (BLUE) - Net earnings per share growth forecast for next year|Expected net earnings per share growth next year ImmunoPrecise Antibodies Ltd. (IPA)|Net earnings per share growth forecast for next year Omega Therapeutics|Net earnings per share growth forecast for next year OMIC|Earnings growth forecast for next year RGLS|Consensus forecast of earnings per share growth for next year Syros Pharmaceuticals Inc.|Earnings growth forecast for next year TBIO (Codex DNA)|TCON (TRACON Pharmaceuticals, Inc) - Net earnings per share change forecast for next year|Unity Biotechnology - Earnings growth forecast for next year
